SURMOUNT-4 (PMID 38078870) used a withdrawal design adults stabilised on tirzepatide were re-randomised to continue or switch to placebo
Monitoring and Adjustments Patients using tirzepatide should have regular follow-up appointments to monitor their response to the medication, side effects , and any potential adjustments to the dose
In trials, serious reactions were reported in 0.1% of tirzepatide-treated and 0% of placebo-treated patients
At UniQ Laser Center, our skilled team of wellness providers is proud to offer Vitamin B12 injections at our Watertown, and Canton, MA locations
SeekPeptides provides comprehensive safety guides and side effect comparison resources that help researchers anticipate and manage common adverse events across the GLP-1 peptide class
Current guidelines recommend the use of SGLT2 inhibitors to prevent adverse CV outcomes in patients with diabetes and established CVD or with multiple CV risk factors